News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Brenda Martone MSN, ANP-BC, AOCNP

Advertisement

Articles by Brenda Martone MSN, ANP-BC, AOCNP

Brenda Martone

Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate Cancer

ByBrenda Martone MSN, ANP-BC, AOCNP
May 15th 2023

Brenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.

Advertisement

Latest Updated Articles

  • Brenda Martone
    Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate Cancer

    Published: May 15th 2023 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Improving Access to Supportive Care on an Organizational Level, With Korie Bigbee

2

Managing Acute and Late Adverse Effects of Breast Cancer Radiation

3

The “Owners” and “Managers” in the Peer-to-Peer Process: What an APP Should Know

4

Comorbidities, Quality of Life, Efficacy, and Safety in Expanding SubQ Use

5

An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us